All ICD10 Codes

DRG 017

Medical DRG

Autologous Bone Marrow Transplant without CC/MCC

TypeMedical

What is MS-DRG 017?

MS-DRG 017 is a Medical Medicare Severity Diagnosis Related Group without a significant Complication or Comorbidity. For FY 2026 it carries a relative weight of 5.4323 with a geometric mean length of stay of 8.3 days and an arithmetic mean of 11.5 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.

Classification
Medical DRG
Diagnosis-driven grouping
MDC
Pre-MDC / Multi-MDC
Linked Codes
0 diagnosis
22 procedure

FY 2026 Payment Data

Official values from Table 5 of the FY 2026 IPPS Final Rule (CMS).

Relative Weight
5.4323
Payment multiplier vs. average case (1.0)
Geometric Mean LOS
8.3 days
Used for transfer payment calculations
Arithmetic Mean LOS
11.5 days
Average length of stay
Post-Acute Transfer
No
Not subject to the transfer policy

Related MS-DRGs in This Severity Group

The same clinical condition is split into separate DRGs by complication severity. MCC pays more than CC, which pays more than no CC/MCC.

DRGTitleRel. WeightGMLOS
016Autologous Bone Marrow Transplant with CC/MCC5.929716.1 days
017Autologous Bone Marrow Transplant without CC/MCCThis page5.43238.3 days

Linked ICD-10-PCS Procedure Mappings

  • 30233C0

    Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Percutaneous Approach

    BillableSection 3
  • 30233G0

    Transfusion of Autologous Bone Marrow into Peripheral Vein, Percutaneous Approach

    BillableSection 3
  • 30233X0

    Transfusion of Autologous Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach

    BillableSection 3
  • 30233Y0

    Transfusion of Autologous Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach

    BillableSection 3
  • 30243C0

    Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Central Vein, Percutaneous Approach

    BillableSection 3
  • 30243G0

    Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach

    BillableSection 3
  • 30243X0

    Transfusion of Autologous Cord Blood Stem Cells into Central Vein, Percutaneous Approach

    BillableSection 3
  • 30243Y0

    Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach

    BillableSection 3
  • XW1337A

    Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10

    BillableSection X
  • XW133B8

    Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW133F8

    Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW133G8

    Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW133H9

    Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9

    BillableSection X
  • XW133J8

    Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW133SB

    Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11

    BillableSection X
  • XW1437A

    Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10

    BillableSection X
  • XW143B8

    Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW143F8

    Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW143G8

    Transfusion of Atidarsagene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW143H9

    Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9

    BillableSection X
  • XW143J8

    Transfusion of Exagamglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW143SB

    Transfusion of Mozafancogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 11

    BillableSection X